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Ever since eukaryotes subsumed the bacterial
ancestor of mitochondria, the nuclear and mitochon-
drial genomes have had to closely coordinate their
activities, as each encode different subunits of the
oxidative phosphorylation (OXPHOS) system. Mito-
chondrial dysfunction is a hallmark of aging, but its
causes are debated. We show that, during aging,
there is a specific loss of mitochondrial, but not
nuclear, encoded OXPHOS subunits. We trace the
cause to an alternate PGC-1a/b-independent path-
way of nuclear-mitochondrial communication that is
induced by a decline in nuclear NAD+ and the accu-
mulation of HIF-1a under normoxic conditions, with
parallels to Warburg reprogramming. Deleting
SIRT1 accelerates this process, whereas raising
NAD+ levels in old mice restores mitochondrial
function to that of a young mouse in a SIRT1-depen-
dent manner. Thus, a pseudohypoxic state that
disrupts PGC-1a/b-independent nuclear-mitochon-
drial communication contributes to the decline in
mitochondrial function with age, a process that is
apparently reversible.
INTRODUCTION
One of the most conserved and robust phenomena in biology is
a progressive decline in mitochondrial function with age, leading
to a loss of cellular homeostasis and organismal health (Lanza1624 Cell 155, 1624–1638, December 19, 2013 ª2013 Elsevier Inc.and Nair, 2010; Wallace et al., 2010). There is considerable
debate, however, about why mitochondrial homeostasis is
disrupted in the first place. The original idea of Harman, that
reactive oxygen species (ROS) from mitochondria are a primary
cause of aging (Harman, 1972), has been challenged by recent
studies of long-lived species and genetically altered animals (La-
pointe and Hekimi, 2010).
Though most mitochondrial genes have been transferred
to the nuclear genome, 13 subunits of the oxidative phos-
phorylation (OXPHOS) system remain, demanding functional
communication between the nucleus and mitochondria to form
stoichiometric OXPHOS complexes. This is mediated in large
part by the peroxisome proliferator-activated receptor-g coacti-
vators a and b (PGC-1a and PGC1-1b), which along with NRF-1
and -2, induce nuclear-encoded proteins, such as TFAM (mito-
chondrial transcription factor A), that carry out the replication,
transcription, and translation of mitochondrial DNA (mtDNA)
(Larsson, 2010).
Mammalian sirtuins (SIRT1-7) are a conserved family of NAD+-
dependent lysine-modifying acylases that control physiological
responses to diet and exercise (Haigis and Sinclair, 2010). The
expression of SIRT1, an NAD+-dependent deacetylase, is
elevated in a number of tissues following calorie restriction (CR)
(Cohen et al., 2004), an intervention that extends lifespan in
diverse species. Overexpression or pharmacological activation
of SIRT1 reproducesmany of the health benefits of CR, including
protection from metabolic decline, cardiovascular disease, can-
cer, and neurodegeneration (Haigis and Sinclair, 2010; Libert and
Guarente, 2013). Some of the health benefits of SIRT1 have also
been linked to improvedmitochondrial function (Baur et al., 2006;
Gerhart-Hines et al., 2007; Price et al., 2012; Rodgers et al.,
2005). Indeed, increased expression of neuronal SIRT1 extends
mouse lifespan (Satoh et al., 2013), though its role in aging in
lower organisms has been challenged (Burnett et al., 2011).
A hallmark of cancer is a shift away from OXPHOS toward
anaerobic glycolysis that provides cells with sufficient substrates
for biomass. This metabolic reprogramming, known as the
Warburg effect (Warburg, 1956), is driven by several different
pathways, includingmTOR, c-Myc, and hypoxia-inducible factor
1 (HIF-1a) (Dang, 2012). Interestingly, SIRT1 increases HIF-1a
transcriptional activity (Lim et al., 2010), SIRT3 destabilizes
HIF-1a protein (Bell et al., 2011; Finley et al., 2011), and SIRT6
functions as a HIF-1a corepressor (Zhong et al., 2010), raising
the possibility that HIF-1amay also be relevant to aging. Consis-
tent with this, in C. elegans, Hif-1 regulates lifespan and the
response to CR (Leiser and Kaeberlein, 2010). A role for HIF-1a
in mammalian aging, however, has not been explored.
In this study, we provide evidence for a PGC-1a/b-indepen-
dent pathway of mitochondrial regulation that plays a role in
the aging process. Activity of this pathway declines during aging
due to changes in nuclear NAD+ levels, causing a pseudo-
hypoxia-driven imbalance between nuclear- andmitochondrially
encoded OXPHOS subunits—a process that is prevented by CR
and is reversed by raising NAD+, with implications for treating
age-related diseases, including cancer.
RESULTS
Aging Leads to a Specific Decline in Mitochondrially
Encoded Genes
Aging is associated with disruption of mitochondrial homeosta-
sis, but the underlying mechanisms are unclear. As in previous
reports (Lanza and Nair, 2010), we observed a progressive,
age-dependent decline in OXPHOS efficiency with age in skel-
etal muscle (Figures 1A and 1B). By 22 months of age, ATP
content and complex IV (COX) activity were decreased, even
more so by 30months of age. Although mtDNA content declined
at both ages, the integrity of mtDNA was only lower in the
30 month olds (Figures 1C and 1D). Together with previous
reports (Lapointe and Hekimi, 2010), this suggested an aging
mechanism that disrupts OXPHOS prior to the accumulation of
significant mtDNA damage.
A clue came from observations that the activity of OXPHOS
complexes I, III, and IV decline with age, but complex II, the
only complex composed exclusively of nuclear-encoded sub-
units, does not (Kwong and Sohal, 2000). Thus, we tested
whether OXPHOS decline might be due to the specific loss of
mitochondrially encoded transcripts. Mitochondrially encoded
OXPHOSmRNAs (ND1,Cytb, COX1, ATP6) were all significantly
lower at 22 months relative to 6 month olds, whereas those
encoded by the nuclear genome (NDUFS8, SDHb, Uqcrc1,
COX5, ATP5a) remained unchanged; but by 30 months of age,
both the nuclear- and the mitochondrially encoded mRNAs
were lower (Figures 1E). Protein levels of the mitochondrially en-
coded COX2 gene were decreased at 22 months, but COX4, a
nuclear-encoded subunit, was only slightly lower. By 30 months,
both proteins were reduced relative to young mice (Figure 1F).
The mitochondrial unfolded protein response (mtUPR) has
been recently linked to longevity (Durieux et al., 2011;
Houtkooper et al., 2013; Mouchiroud et al., 2013); however,Cunder these conditions there was no evidence of a mtUPR at
22 months of age (Figure S1A available online).
Knockout of SIRT1 Mimics Aging by Decreasing
Mitochondrial, but Not Nuclear-Encoded, OXPHOS
Components
We wondered whether the specific decline in mitochondrially
encoded OXPHOS components in aged mice might be due, in
part, to a loss of SIRT1 activity. To test this, we utilized an
adult-inducible SIRT1 knockout mouse (SIRT1-iKO) (Price
et al., 2012), which circumvents the developmental abnormal-
ities of germline SIRT1 knockouts. SIRT1 was deleted at
2–4 months of age, and skeletal muscle was analyzed
2–6 months later. As expected, the mRNA levels of all 13 mito-
chondrially encoded OXPHOS genes and the two rRNAs were
reduced in the SIRT1 iKO mice compared to wild-type controls
(Figures 1G and S1B). Strikingly, there was no decrease in the
expression of any of the nuclear-encoded components under
fed conditions (Figure 1G). Again, protein levels of mitochondri-
ally encoded COX2 were significantly decreased, whereas the
nuclear-encoded COX4 was unaltered (Figure 1H), coincident
with a decline in complex IV (COX), but not complex II (SDH),
activity (Figures S1D and S1E). Similar to old mice, cellular ATP
levels and mtDNA content were reduced (Figures 1I and 1J),
with no apparent induction of mtUPR (Figure S1C).
Given that SIRT1 maintains mitochondrial mass by increasing
PGC-1a activity, we were surprised to see that, under these
basal conditions (i.e., the fed state), there was no effect of
SIRT1 deletion on mitochondrial mass (Figure 1K). To under-
stand why, we cultured SIRT1 iKO primary myoblasts and
induced Cre-mediated deletion of the SIRT1 catalytic core
ex vivo. After 12 hr, only the mitochondrially encoded OXPHOS
mRNAs decreased (Figure 1L). Again, mtDNA content and mito-
chondrial membrane potential declined, with no change in mito-
chondrial mass (Figures 1M, S2A, and S2B). By 48 hr, mRNA
from both the nuclear- and mitochondrially encoded genes had
decreased, with a loss of mitochondrial mass and a further
decrease in membrane potential (Figures 1L, 1M, S2A, and
S2B). These data suggested that loss of SIRT1 results in a
biphasic disruption of mitochondrial homeostasis.
Nuclear NAD+ Levels Regulate Mitochondrially Encoded
Genes
Because there was no decline in SIRT1 protein with age (Fig-
ure S2E), we hypothesized that SIRT1 activity might be com-
promised in old mice due to a paucity of NAD+. Recent studies
show that NAD+ levels are regulated independently in different
cell compartments and that overall NAD+ levels decline during
aging (Braidy et al., 2011; Massudi et al., 2012; Yang et al.,
2007). However, it is not clear in which cellular compartment(s)
is NAD+ relevant to aging (Canto´ and Auwerx, 2011). Consistent
with other reports (Braidy et al., 2011; Massudi et al., 2012),
there was less total NAD+ in the skeletal muscle of elderly
mice (Figure 2A). To determine which compartment might be
responsible, we manipulated NAD+ levels in the different com-
partments by independently knocking down isoforms of nico-
tinamide mononucleotide adenylyltransferase, which regulate
NAD+ levels in the nucleus (NMNAT1), golgi/cytoplasmell 155, 1624–1638, December 19, 2013 ª2013 Elsevier Inc. 1625
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Figure 1. Aging and Loss of SIRT1 Leads to a Specific Decline in Mitochondrial-Encoded Genes and Impairment in Mitochondrial
Homeostasis in Skeletal Muscle
(A) ATP content of 6-, 22-, and 30-month-old mice (n = 5, *p < 0.05 versus 6-month-old mice).
(B) Cytochrome c oxidase (COX) activity (n = 5, *p < 0.05 versus 6-month-old animals).
(C and D) Mitochondrial DNA content (C) and DNA integrity (D) (n = 5, *p < 0.05 versus 6-month-old animals).
(legend continued on next page)
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(NMNAT2), and mitochondria (NMNAT3) (Berger et al., 2005).
Knockdown of NMNAT2 or NMNAT3 had no effect on OXPHOS
genes, whereas knockdown of NMNAT1 resulted in a specific
reduction in the expression of mitochondrially encoded
OXPHOS, mtDNA content, and ATP levels (Figures 2B–2F).
These results indicated that increasing the production of NAD+
within the nuclear pool might stimulate mitochondria. Overex-
pression of NMNAT1 in skeletal muscle of 10- to 12-month-old
mice dramatically increased the expression of mitochondrially
encoded OXPHOS genes (Figure 2G). Overexpression of
NMNAT1 in primary myoblasts produced a similar effect that
was SIRT1 dependent (Figure 2H). Together, these data indi-
cated that mitochondria are regulated by nuclear NAD+ and
that the impairment in OXPHOS function during aging may be
precipitated by depletion of the nuclear NAD pool.
SIRT1 Can Regulate Mitochondria through a PGC-1a/
b-Independent Pathway
A central dogma in the sirtuin field is that SIRT1 promotes mito-
chondrial function in response to fasting and CR by deacetylat-
ing PGC-1a (Gerhart-Hines et al., 2007; Rodgers et al., 2005).
Consistent with this, SIRT1 iKO animals failed to upregulate
both nuclear- and mitochondrially encoded OXPHOS genes in
response to fasting (Figure S2C). However, our findings in fed
animals (see Figure 1) indicated that SIRT1 can regulate mito-
chondrial genes independently of PGC-1a. To test this, we
examined primary myotubes from PGC-1a/b knockout (KO)
mice (Zechner et al., 2010) and from PGC-1a muscle-specific
null mice (Handschin et al., 2007), and we saw no defect in the
ability of SIRT1 and NMNAT1 to induce mitochondrially encoded
OXPHOS genes (Figures 2I and 2J). Thus, SIRT1 can induce
OXPHOS genes in the absence of PGC-1a/b (Figure S2D).
SIRT1 Regulates Mitochondrially Encoded Genes
through HIF-1a
Next, we sought to understand how SIRT1 regulates mitochon-
dria independently of PGC-1a/b. Analysis of SIRT1 iKO animals
indicated that genes involved in glycolysis were upregulated,
with increased lactate levels (Figures 3A and 3B) and a switch
from slow-twitch oxidative fibers (MyHCIIa) to fast-twitch glyco-
lytic fibers (MyHCIIb) (Figure S1F). These metabolic changes
were reminiscent of Warburg remodeling of metabolism in
cancer cells, which is known to be mediated, in part, by the
stabilization of the transcription factor HIF-1a (Majmundar
et al., 2010). The levels of HIF-1a and the expression of HIF-1a(E) Expression of nuclear- and mitochondrially encoded genes (n = 5, *p < 0.05 v
(F) Immunoblot for COX2 and COX4 in 6-, 22-, and 30-month-old mice.
(G) Expression of nuclear- (NDUFS8,NDUFAS, SDHb, SDHd,Uqcrc1,Uqcrc2,CO
ND2, ND3, ND4, ND4l, ND5, ND6, Cytb, COX1, COX2, COX3, ATP6, and ATP8)
(H and I) (H) Immunoblot for COX2 and COX4 and (I) ATP content in WT and SIR
(J) Mitochondrial DNA content of WT and SIRT1 iKO mice (n = 5, *p < 0.05 versu
(K) Electron microscopy of gastrocnemius from WT and SIRT1 iKO mice and mit
(L) Expression of nuclear- and mitochondrially encoded genes in SIRT1 flox/flox
induce SIRT1 excision for 6, 12, 24, and 48 hr (n = 4, *p < 0.05 versus vehicle).
(M) Mitochondrial mass by NAO fluorescence in SIRT1 flox/flox Cre-ERT2 primary
24, and 48 hr (n = 4, *p < 0.05 versus vehicle).
Nuclear- and mitochondrially encoded genes were ND1, Cytb, COX1, ATP6 and
gastrocnemius unless otherwise stated. Values are expressed as mean ± SEM.
Ctarget genes were considerably higher in the SIRT1 iKO (Figures
3C and S3A). Despite being cultured under normoxic conditions,
primary myoblasts deleted for SIRT1 also had increased HIF-1a
protein levels and activity of a HIF-1a reporter (Figures 3C and
S3B). Reducing NAD+ levels, either by knocking down NMNAT1
or by treating cells with lactate (which decreases the NAD+/
NADH ratio), also caused HIF-1a protein stabilization (Figures
3D, 3E, and S3C).
HIF-1a has been studied extensively in cancer and during
hypoxia; however, its role in normal physiology remains largely
unknown. To better understand this, HIF-1a was stabilized
ectopically in vivo by deleting the EglN1 gene encoding HIF
prolyl hydroxylase 2 (PHD2) (Minamishima et al., 2008). Upon
EglN1 deletion and HIF-1a stabilization in muscle, there was a
specific decline in mtDNA content and decreased levels of
mitochondrially encoded, but not nuclear-encoded, OXPHOS
mRNA, paralleling the effects of SIRT1 deletion and normal aging
(Figures 3F–3H). Pharmacological stabilization of HIF-1a inPGC-
1a/b knockout myotubes reduced expression of mitochondrially
encoded genes (Figures 3I and S3D), whereas treating PGC-
1a/b KO cells with pyruvate (to increase NAD+ levels) up-
regulated mitochondrially encoded genes, an effect that was
prevented by stabilization of HIF-1a (Figure S3E). Stabilization
of HIF-1a in primary cells and transgenic mice blocked the ability
of SIRT1 to upregulate mitochondrially encoded genes and
increase ATP levels, with a specific loss of mitochondrially
encoded mRNAs (Figures 3I–3L and S3F–SFI). Overexpression
of a stabilized mutant version of the related factor HIF-2a did
not have the same effect (Figures 3J–3L and S3I), demonstrating
that the inhibition of OXPHOS and mitochondrially encoded
genes is HIF-1a specific. In primary myoblasts lacking HIF-1a,
deletion of SIRT1 had no effect on mtDNA content, mitochond-
rially encoded gene expression, or ATP levels (Figures 3M–3P).
Together, our results show that HIF-1a, but not HIF-2a, regulates
mitochondria in response to SIRT1 activity, which is under the
control of nuclear NAD+ levels.
SIRT1 Stabilizes HIF-1a via VHL
HIF-1a can be stabilized by ROS originating from complex III
of the ETC as part of retrograde response (Bell et al., 2007).
Six hours after inducing SIRT1 deletion in primary myoblasts,
HIF-1a levels increased (Figure 5F), and by 12 hr, mitochondrial
homeostasis was impaired (Figures 1L, S2A, and S2B). Yet, ROS
levels did not increase until the 24 hr time point (Figure S4A).
Myoblasts depleted of mitochondrial DNA (rho0), which areersus 6-month-old animals).
X5b,Cox6a1, ATP5a1, and ATPc1) and mitochondrially encoded genes (ND1,
in WT and SIRT1 iKO mice (n = 5, *p < 0.05 versus WT).
T1 iKO mice (n = 5, *p < 0.05 versus WT).
s WT).
ochondrial area (n = 4).
Cre-ERT2 primary myoblasts treated with vehicle (0 hr) or tamoxifen (OHT) to
myoblasts treated with vehicle (0 hr) or OHT to induce SIRT1 excision for 6, 12,
NDUFS8, SDHb, Uqcrc1, COX5b, ATP5a1, respectively. Tissue samples are
See also Figure S1.
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Figure 2. Nuclear NAD+ Levels Regulate Mitochondrial-Encoded Genes and Mitochondrial Homeostasis through SIRT1, Independently of
PGC-1a/b
(A) NAD+ levels in gastrocnemius of 6-, 22-, and 30-month-old mice (n = 5, *p < 0.05 versus 6-month-old mice).
(B–D) Expression of nuclear- andmitochondrially encoded genes in primary myoblasts transduced withNMNAT1 (B),NMNAT2 (C),NMNAT3 (D), or nontargeting
shRNA (n = 4, *p < 0.05 versus shNT).
(E and F)Mitochondrial DNA content and (H) ATP content (I) in primary myoblasts transducedwithNMNAT1 or nontargeting shRNA (n = 4, *p < 0.05 versus shNT).
(G) Expression of mitochondrially encoded genes in tibialis of 10- to 12-month-old mice overexpressing NMNAT1 compared to the contralateral tibialis muscle
treated with vehicle (n = 4, *p < 0.05 versus vehicle).
(H) Expression of mitochondrially encoded genes in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with vehicle or OHT to induce SIRT1 excision infected
with adenovirus overexpressing NMNAT1 or empty vector (n = 4, *p < 0.05 versus vehicle empty vector).
(I and J) Expression of nuclear- andmitochondrially encoded genes inWT and PGC-1a/b knockout myotubes treated with adenovirus overexpressing SIRT1 (I) or
NMNAT1 (J) (n = 4, *p < 0.05 versus WT empty; #p < 0.05 versus PGC-1a/b KO empty).
Nuclear- and mitochondrially encoded genes were ND1, Cytb, COX1, ATP6 and NDUFS8, SDHb, Uqcrc1, COX5b, ATP5a1, respectively. Tissue samples are
gastrocnemius muscle unless otherwise stated. Values are expressed as mean ± SEM. See also Figure S2.
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unable to produce ROS and signal to the nucleus (Chandel and
Schumacker, 1999), were similar to the parental control cells
(Figure S4B), indicating that ROS and retrograde signaling are
not the cause of HIF-1a stabilization.
HIF-1a stability has been previously reported to be regulated
by acetylation of lysine 709 (Geng et al., 2011). To test whether
SIRT1-mediated deacetylation was the mechanism, we mutated
K709 to glutamine (an acetylation mimetic) or to arginine
(nonacetylated mimetic), with K674 serving as a negative control
(Lim et al., 2010). Neither of the K709 substitutions stabilized
HIF-1a, nor were they affected by SIRT1 deletion (Figure S4C),
indicating that SIRT1 does not regulate HIF-1a protein stability
by deacetylating K709.
HIFa proteins are regulated by a proteasomal degradation
mechanism mediated by the Von Hippel-Lindau (VHL) E3
ubiquitin ligase that recognizes hydroxylated proline residues
on HIFa (Kaelin, 2008). Knockout of SIRT1 did not affect HIF-1a
hydroxylation (FigureS4D), but in theSIRT1 iKOmouseand trans-
genic overexpressor the levels of SIRT1 correlated with VHL
levels (Figures 4A–4D). VHL promoter activity was not altered by
SIRT1 deletion, suggesting posttranscriptional regulation (Fig-
ures 4F and 4G). HIF-2a was also stabilized by SIRT1, though
HIF-2a target genes were not upregulated (Figures S4E and
S4F). The re-establishment of SIRT1 eliminated HIF-1a protein
and restored levels of mitochondrial OXPHOS mRNA in SIRT1
iKO myoblasts, but these effects were lost when VHL was
knocked down (Figures 4H–4J; also see Figure 5F). Thus, SIRT1
is constantly required to maintain mitochondrial homeostasis by
inducing VHL and by ensuring that HIF-1a is degraded efficiently.
SIRT1-HIF-1a Regulates Mitochondria by Modulating
c-Myc’s Ability to Activate TFAM
These results raised the question of how HIF-1a, a nuclear pro-
tein, inhibits mitochondrial OXPHOS genes. Analysis of gene
expression in SIRT1 iKO mice identified the nuclear-encodedFigure 3. Loss of SIRT1 Induces a Pseudohypoxic State that Disrupts
(A and B) HK2, PFKM, PKM, and LDHA mRNA (A) and lactate levels (B) of WT an
(C) Immunoblot for HIF-1a and tubulin in WT and SIRT1 iKOmice and in SIRT1 flox
excision for 24 hr (SIRT1 iKO).
(D) Immunoblot for HIF-1a and tubulin in primary myoblasts transduced with NM
(E) Immunoblot of HIF-1a and tubulin in primary myoblasts treated with pyruvate
(F) Immunoblot for HIF-1a and tubulin in WT and EglN1 KO mice.
(G) Expression of nuclear- and mitochondrially encoded genes of WT and EglN1
(H) Mitochondrial DNA content of WT and EglN1 KO mice (n = 5, *p < 0.05 versu
(I) Expression of mitochondrially encoded genes in PGC-1a/b KO myotubes tre
stabilizing compound DMOG (n = 4, *p < 0.05 versus empty DMSO; #p < 0.05 ve
(J) Immunoblot for HA tag and tubulin in control and C2C12 cells overexpressin
HIF-2a DPA).
(K) Expression of nuclear- versus mitochondrially encoded genes in HIF-1a DPA
(L) Expression of mitochondrially encoded genes in HIF-1aDPA or HIF-2aDPA C2
vector; #p < 0.05 versus SIRT1 OE).
(M) Immunoblot for HIF-1a and tubulin in SIRT1 flox/flox Cre-ERT2 primary myob
(N) Mitochondrial DNA in SIRT1 flox/flox Cre-ERT2 primary myoblasts transduce
SIRT1 excision (SIRT1 iKO) (n = 4, *p < 0.05 versus shNT vehicle; #p < 0.05 vers
(O) Expression of mitochondrially encoded genes in SIRT1 flox/flox Cre-ERT2 prim
OHT to induce SIRT1 excision (SIRT1 iKO) (n = 4, *p < 0.05 versus shNT vehicle;
(P) ATP content in SIRT1 flox/flox Cre-ERT2 primary myoblasts transduced with H
excision (n = 5, *p < 0.05 versus shNT vehicle; #p < 0.05 versus shNT SIRT1 iKO
Nuclear- and mitochondrially encoded genes were ND1, Cytb, COX1, ATP6 and
gastrocnemius unless otherwise stated. Values are expressed as mean ± SEM.
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S5A). Consistent with this, TFAM promoter activity in SIRT1
iKO myoblasts was greatly reduced (Figure 5B), the reintroduc-
tion of TFAM into SIRT1 iKO cells restored levels of mitochond-
rially encodedmRNAs and ATP (Figure 5C-E), and in time course
studies, TFAM levels declined 6 hr after VHL and HIF-1a
(Figure 5F).
Knockdown of ARNT, a HIF-1a transcriptional binding partner
(Wang et al., 1995), had no appreciable effect on mitochondrially
encoded OXPHOS genes and ATP levels (Figures S5B–S5D),
indicating that HIF-1a acts via a different mechanism. In cancer
cells, metabolic reprogramming is mediated by crosstalk be-
tween HIF-1a and c-Myc (Gordan et al., 2007), raising the
possibility that c-Myc was the missing factor. In fact, c-Myc
DNA-binding sites are found at mitochondrial biogenesis genes
(Kim et al., 2008; Li et al., 2005). Deletion of SIRT1 in primary
myoblasts increased the binding between HIF-1a and c-Myc
and reduced c-Myc reporter activity (Figures 5G and S5E).
Similarly, knockdown of c-Myc completely blocked the ability
of SIRT1 to induce mitochondrially encoded mRNAs andmtDNA
(Figures S5F–S5H). Conversely, overexpression of c-Myc in
myoblasts treated with a SIRT1 inhibitor, EX-527, prevented
loss of mtDNA, mitochondrially encoded mRNA, and cellular
ATP levels (Figures S5I–S5L).
We tested whether c-Myc directly controls TFAM promoter
in myoblasts and is modulated by SIRT1-HIF-1a. TFAM is
known to be regulated by PGC-1a, which interacts with NRF
1/2 bound at positions 311 and 154 in the TFAM promoter
(Figure 5H). Knockdown of c-Myc reduced TFAM promoter
activity (Figure 5I), consistent with a study in cancer cells (Li
et al., 2005). We identified a putative c-Myc consensus
sequence, CACGTG, 1,028 bp upstream of the ATG site—the
mutation of which decreased promoter activity by about half
without affecting PGC-1a-mediated induction (Figures 5J and
5K). Overexpression of SIRT1 also induced the TFAM promoterMitochondrial-Encoded Genes and Mitochondrial Homeostasis
d SIRT1 iKO mice (n = 5, *p < 0.05 versus WT).
/flox Cre-ERT2 primary myoblasts treated with vehicle or OHT to induce SIRT1
NAT1 or nontargeting shRNA.
, lactate, or vehicle for 24 hr.
KO mice (n = 5, *p < 0.05 versus WT).
s WT).
ated with adenovirus overexpressing SIRT1 treated with DMSO or the HIF-
rsus SIRT1 OE DMSO).
g either HIF-1a or HIF-2a with the proline residues mutated (HIF-1a DPA and
or HIF-2a DPA C2C12 cells (n = 6, *p < 0.05 versus empty vector).
C12 cells with adenovirus overexpressing SIRT1 (n = 4, *p < 0.05 versus empty
lasts transduced with HIF-1a or nontargeting shRNA and treated with DMOG.
d with HIF-1a or nontargeting shRNA, treated with vehicle or OHT to induce
us shNT SIRT1 iKO).
ary myoblasts transduced withHIF-1a or nontargeting shRNA and treated with
#p < 0.05 versus shNT SIRT1 iKO).
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NDUFS8, SDHb, Uqcrc1, COX5b, ATP5a1, respectively. Tissue samples are
See also Figure S3.
SIRT1 iKO  WT 
VHL 
Tubulin 
SIRT1-Tg  WT 
VHL 
Tubulin 
A B 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
V
H
L 
m
R
N
A 
(r
el
at
iv
e 
ex
pr
es
si
on
) 
WT SIRT1 iKO 
0.0 
1.0 
2.0 
3.0 
4.0 
5.0 
V
H
L 
m
R
N
A 
(r
el
at
iv
e 
ex
pr
es
si
on
) 
WT SIRT1-Tg 
C D 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
V
H
L 
pr
om
ot
er
 
(r
el
at
iv
e 
ac
tiv
ity
) 
Vehicle SIRT1 iKO 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
V
H
L 
pr
om
ot
er
 
(r
el
at
iv
e 
ac
tiv
ity
) 
Empty SIRT1 OE 
Tubulin 
HIF-1  
VHL 
22 mo  6 mo 
VHL 
Tubulin Tubulin 
HIF-1  
shNT shVHL#1 shVHL#2 
Vehicle 
SIRT1 iKO 
SIRT1 
   +    -      -     +   -    -     +     -     -         
    -    +     +     -   +   +     -     +    + 
    -     -     +     -   -    +     -     -     +         
shNT + Empty 
shNT + SIRT1 OE 
shVHL#1 + SIRT1 OE 
shVHL#2 + SIRT1 OE 
F E 
I J 
* 
* 
0.0 
1.0 
2.0 
3.0 
4.0 
5.0 
m
t-e
nc
od
ed
 m
R
N
A 
(r
el
at
iv
e 
ex
pr
es
si
on
) 
* 
# # 
G 
H 
Figure 4. SIRT1 Regulates HIF-1a Stabilization in Skeletal Muscle through Regulation of VHL Expression
(A and B) Immunoblot for VHL and tubulin in gastrocnemius of WT and SIRT1 iKO mice (A) and WT and SIRT1-Tg mice (B).
(C and D) VHL mRNA in WT and SIRT1 iKO mice (C) and WT and SIRT1-Tg mice (D). Values normalized to WT mice (n = 5, *p < 0.05 versus WT).
(E) Immunoblot for VHL, HIF-1a, and tubulin in gastrocnemius of 6- and 22-month-old mice.
(F) VHL promoter activity in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with vehicle or OHT for 24 hr to induce SIRT1 excision (SIRT1 iKO). Luciferase
values normalized to vehicle cells (n = 5).
(G) VHL promoter activity in primary myoblasts with adenovirus expressing SIRT1 or empty vector. Luciferase values normalized to empty vector cells (n = 5).
(H) Immunoblot for VHL and tubulin in SIRT1 flox/flox Cre-ERT2 primary myoblasts transduced with VHL or nontargeting shRNA.
(I) Representative immunoblot for HIF-1a in SIRT1 flox/flox Cre-ERT2 primary myoblasts transduced with VHL or nontargeting shRNA and treated with OHT for
24 hr (SIRT1 iKO), after which SIRT1 was added back by adenoviral infection.
(J) Expression of mitochondrially encoded genes in primary myoblasts transduced with VHL or nontargeting shRNA and treated with adenovirus expressing
SIRT1 or empty vector (n = 5, *p < 0.05 versus shNT empty; #p < 0.05 versus shNT SIRT1 OE). Mitochondrially encoded genes wereND1,Cytb,COX1, and ATP6.
Values are expressed as mean ± SEM. See also Figure S4.reporter, and mutation of the c-Myc binding site blocks this
effect (Figure 5L). Chromatin IP experiments detected an inter-
action between c-Myc and the TFAM promoter, which was
markedly reduced when SIRT1 was deleted, but not when
HIF-1a was also knocked down (Figures 5M–O). We did not
detect direct HIF-1a binding to TFAM (Figures 5M and 5N),
with LDHA as a positive control (Figures S5M and S5N).
Together, these data provide the first direct link between
HIF-1a and the regulation of mitochondrially encoded genes inCskeletal muscle and identify a mechanism of PGC-1a/b-inde-
pendent regulation of mitochondrial function.
AMPK Functions as a Switch between PGC-
1a-Dependent and -Independent Pathways Driven by
SIRT1
Next, we determined the mechanisms that determine whether
SIRT1 utilizes the PGC-1a-dependent or -independent path-
ways. Under conditions of low energy, AMPK-mediatedell 155, 1624–1638, December 19, 2013 ª2013 Elsevier Inc. 1631
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(legend on next page)
1632 Cell 155, 1624–1638, December 19, 2013 ª2013 Elsevier Inc.
phosphorylation of PGC-1a allows it to be deacetylated and
activated by SIRT1 (Canto´ et al., 2009; Gerhart-Hines et al.,
2007; Rodgers et al., 2005), whereas under basal conditions,
acetylation status is primarily regulated by the acetyltransferase
GCN5 (Fernandez-Marcos and Auwerx, 2011). We speculated
that the biphasic decline in OXPHOS subunits (in Figure 1L)
might be due to AMPK. In time course experiments following
SIRT1 deletion, AMPK activation occurred after 48 hr, well after
the decline in VHL-TFAM and mitochondrial genes (Figures 1L–
1M and 6A) but coincident with the decline in nuclear-encoded
OXPHOS genes and mitochondrial mass (see Figures 1L–1M).
An AMPK dominant-negative adenovirus (AMPK-DN) prevented
the decline of nuclear OXPHOS mRNAs at 48 hr (Figures 6B and
6C), whereas forced maintenance of TFAM prevented AMPK
activation (Figures 6D, 5D, and 5E). Together, these results
strongly suggest that AMPK is the switch between the
PGC-1a-dependent and -independent pathways. In this model,
AMPK activation occurs in the absence of SIRT1 only when ATP
levels fall below a threshold. Consistent with this, AMPK was un-
changed under fed conditions in the SIRT1 iKO mice and 22-
month-old wild-type mice but was markedly increased in fasting
animals, when we observe changes in both nuclear- and mito-
chondrially encoded OXPHOS genes (Figure 6E and 6F).
Increasing NAD+ Levels Restores Mitochondrial
Homeostasis through the SIRT1-HIF-1a-c-Myc Pathway
CR is known to delay numerous diseases of aging in mammals,
including cancer and type 2 diabetes. Interestingly, CR (30%–
40% instituted at 6 weeks) completely prevented the decline in
VHL and the increase in HIF-1a that occurs in ad-libitum (AL)-
fed 22-month-old mice (Figure 7A). The observed decreases in
NAD+ and ATP levels, COX activity, mtDNA, and mitochondrially
encoded OXPHOS components with age were also prevented
by CR (Figures 7B–7D, S6A, and S6B). Unlike the accumulation
of mutations in mtDNA, the pathway that we describe here
should be rapidly reversible. Treatment of 22-month-old miceFigure 5. SIRT1 Regulates Mitochondrial Homeostasis by Modulation
(A) TFAM mRNA analyzed by qPCR in gastrocnemius of WT and SIRT1 iKO anim
(B) TFAM promoter activity in SIRT1 flox/flox Cre-ERT2 primary myoblasts treate
luciferase values were normalized to vehicle cells (n = 6, *p < 0.05 versus vehicle
(C) Immunoblot for SIRT1, TFAM, and tubulin in SIRT1 flox/flox Cre-ERT2 primary
24 or 48 hr, after which cells were infected with control or TFAM adenovirus.
(D) Expression of nuclear- versus mitochondrially encoded genes in SIRT1 flox/
(SIRT1 iKO) for 24 or 48 hr, after which cells were infectedwith TFAM adenovirus. V
versus SIRT1 iKO 24 hr; &p < 0.05 versus SIRT1 iKO 48 hr).
(E) ATP content inSIRT1 flox/flox Cre-ERT2 primary myoblasts treatedwith vehicl
SIRT1 iKO 24 hr; &p < 0.05 versus SIRT1 iKO 48 hr).
(F) Immunoblot of SIRT1, VHL, HIF-1a, TFAM, and tubulin in SIRT1 flox/flox Cre-
and in cells treated with OHT for 24 hr, after which SIRT1 was added back by ad
(G) Interaction of HIF-1a and c-Myc determined by immunoprecipitation of H
excise SIRT1.
(H) The c-Myc-binding site on the TFAM promoter.
(I) TFAM promoter activity in primary myoblasts transduced with c-Myc or nonta
(J–L) TFAM promoter full-length activity or withmutation of c-Myc-binding site (D c
empty vector (n = 4, *p < 0.05 versus empty; #p < 0.05 versus D c-Myc empty).
(M andN) Chromatin immunoprecipitation (ChIP) (M) and respective quantification
ERT2 primary myoblasts treated with vehicle or OHT to induce SIRT1 excision (n
(O) ChIP of c-Myc to the TFAM promoter in SIRT1 flox/flox Cre-ERT2 primary my
OHT to induce SIRT1 excision for 24 hr (SIRT1 iKO). Mitochondrially encoded ge
Values are expressed as mean ± SEM. See also Figure S5.
Cfor 1 week with NMN, a precursor to NAD+ that increases
NAD+ levels in vivo (Yoshino et al., 2011), reversed the decline
in VHL and accumulation of HIF-1a (Figures 7E and 7F); reduced
lactate levels; and increased ATP, COX activity, and mitochond-
rially encoded OXPHOS transcripts (Figures 7G–7I and S6D). In
EglN1 and SIRT1 iKOmice, however, NMN failed to inducemito-
chondrially encoded genes or to raise ATP levels (Figures 7J–7L).
Knockdown of NMNAT1 also prevented NMN from inducing
mitochondrially encoded OXPHOS genes (Figure 7M), consis-
tent with nuclear NAD+ being a key regulatory molecule. The
SIRT1 iKO and the 22-month-old mice had increased levels of
markers ofmuscle atrophy and inflammation compared to young
WT mice, along with impaired insulin signaling and insulin-stim-
ulated glucose uptake (Figures S1G–S1J and S6E–S6H). Strik-
ingly, treatment of old mice with NMN reversed all of these
biochemical aspects of aging and switched gastrocnemius
muscle to a more oxidative fiber type (Figures S6E–S6H). How-
ever, we did not observe an improvement in muscle strength
(data not shown), indicating that 1 week of treatment might not
be sufficient to reverse whole-organism aging and that longer
treatments might be required.
DISCUSSION
Impairment in mitochondrial homeostasis is one of the hallmarks
of aging that may underlie common age-related diseases (Lanza
and Nair, 2010; Wallace, 2010). Despite its importance, there is
still controversy as to why mitochondrial homeostasis is dis-
rupted with age and whether this process can be slowed or
even reversed. Here, we present evidence for a PGC-1a/b-inde-
pendent pathway that ensures OXPHOS function and mainte-
nance of mitochondrial homeostasis (Figure 7N). During aging,
however, decline in nuclear energetic state or NAD+ levels re-
duces the activity of SIRT1 in the nucleus, causing VHL levels
to decline and HIF-1a to be stabilized. This program, which likely
evolved to modulate mitochondrial metabolism in response toof the TFAM Promoter through HIF-1a/c-Myc
als. Values were normalized to WT mice (n = 5, *p < 0.05 versus WT).
d with vehicle or OHT to induce SIRT1 excision for 24 hr (SIRT1 iKO). Relative
).
myoblasts treated with vehicle or OHT to induce SIRT1 excision (SIRT1 iKO) for
flox Cre-ERT2 primary myoblasts treated with OHT to induce SIRT1 excision
alues were normalized to vehicle cells (n = 4, *p < 0.05 versus vehicle; #p < 0.05
e or OHT for 24 or 48 hr as in (D) (n = 4, *p < 0.05 versus vehicle; #p < 0.05 versus
ERT2 primary myoblasts treated with vehicle or OHT to induce SIRT1 excision
enoviral infection.
IF-1a in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with OHT to
rgeting shRNA (n = 4, *p < 0.05 versus shNT).
-Myc) in primarymyoblasts overexpressing c-Myc (J),PGC-1a (K),SIRT1 (L), or
by qPCR (N) of c-Myc andHIF-1a to the TFAM promoter inSIRT1 flox/flox Cre-
= 3, *p < 0.05 versus vehicle).
oblasts transduced with HIF-1a or nontargeting shRNA treated with vehicle or
nes were ND1, Cytb, COX1, ATP6.
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Figure 6. AMPK Activity Regulates Switch between PGC-1a-Dependent and -Independent Mechanisms of Mitochondrial Regulation by
SIRT1
(A) Immunoblot for p-AMPK (Thr172) and AMPK in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with vehicle (0 hr) or OHT to induce SIRT1 excision.
(B) Immunoblot for p-ACC (Ser79) and ACC in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with vehicle or OHT for 48 hr (SIRT1 iKO) and infected with
AMPK-DN adenovirus.
(C) Expression of nuclear- and mitochondrially encoded genes as in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with vehicle or OHT (SIRT1 iKO) and
infected with empty or AMPK-DN adenovirus for the same period of time (n = 4, *p < 0.05 versus vehicle; #p < 0.05 versus SIRT1 iKO).
(D) Immunoblot for p-AMPK (Thr172) and AMPK in SIRT1 flox/flox Cre-ERT2 primary myoblasts treated with vehicle or OHT for 24 or 48 hr, after which cells were
infected with control or TFAM adenovirus.
(E) Immunoblot for p-AMPK (Thr172) and AMPK in gastrocnemius of WT and SIRT1 iKO mice under fed and fasted conditions.
(F) Representative immunoblot for p-AMPK (Thr172) and AMPK in gastrocnemius of 6- and 22-month-old mice. Nuclear- and mitochondrially encoded genes
were ND1, Cytb, COX1, ATP6, and NDUFS8, SDHb, Uqcrc1, COX5b, and ATP5a1, respectively.
Values are expressed as mean ± SEM.changes in energy supply, becomes chronically activated in old
mice, inducing a pseudohypoxic state that disrupts OXPHOS, a
phenomenon that is consistent with antagonistic pleiotropy (Wil-
liams and Day, 2003).
One of themore surprising findings is the existence of a SIRT1-
mediated pathway that regulates mitochondria independently of
PGC-1a/b. The data indicate that SIRT1 can regulate these two
pathways in response to the energetic state of the cell. Which
one predominates depends on AMPK activity and the phosphor-
ylation status of PGC-1a (Canto´ et al., 2009).
This study shows that HIF-1a-induced metabolic reprogram-
ming occurs in normal tissue and that it disrupts mitochondrial
homeostasis. We consider the metabolic state of the old mice
as pseudohypoxic because the downstream effects are similar
to hypoxia but occur even when oxygen is abundant, as previ-
ously in type 2 diabetes and cancer (Ido and Williamson, 1997;
Sanders, 2012;Williamson et al., 1993). An interesting implication
is that reprogramming of normal tissue toward a Warburg-like
state may increase ROS and establish a milieu for subsequent
mutations to initiate carcinogenesis, a possibility that may help
explain why cancer risk increases exponentially with age.
All of the main players in the nuclear NAD+-SIRT1-HIF-
1a-OXPHOSpathway are present in lower eukaryotes, indicating
that the pathway evolved early in life’s history. This pathway may1634 Cell 155, 1624–1638, December 19, 2013 ª2013 Elsevier Inc.have evolved to coordinate nuclear-mitochondrial synchrony in
response to changes in energy supplies and oxygen levels,
and its decline may be a conserved cause of aging. In
C. elegans, HIF-1a is known to be a key determinant of lifespan,
though its precise role is still a matter of debate (Leiser and
Kaeberlein, 2010). HIF-1a modulation may have differential
effects on lifespan depending on the animal’s diet or whether
the mtUPR is activated (Dillin et al., 2002; Durieux et al., 2011;
Houtkooper et al., 2013). Though we did not detect mUPR in
skeletal muscle, we do not exclude the possibility that mtUPR
plays a role in other tissues or under different conditions.
Additional studies will be required to elucidate complex feed-
back loops that likely regulate the SIRT1-HIF-1a-Myc-TFAM
pathway. For example, in cancer cells, SIRT1 directly regulates
c-Myc transcriptional activity, either by deacetylation of c-Myc
(Menssen et al., 2012) or by binding c-Myc and promoting its
association with Max (Mao et al., 2011). Given that SIRT3 and
SIRT6 also regulate HIF-1a and compromise respiration (Bell
et al., 2011; Finley et al., 2011; Zhong et al., 2010), it will be inter-
esting to test whether a decline in the activity of other sirtuins
causes a similar loss of TFAM and mitochondrially encoded
OXPHOS components.
How broadly applicable might these findings be? High-fat diet
feeding increases levels of HIF-1a in liver (Carabelli et al., 2011)
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and white adipose tissue, the latter of which correlated with a
decline in mitochondrial gene expression (Krishnan et al.,
2012). Moreover, insulin-resistant human skeletal muscle has a
signature reminiscent of hypoxia (Ptitsyn et al., 2006). In SIRT1
iKO mice, specific dysregulation of mitochondrial OXPHOS
genes is also observed in the heart, demonstrating that the
pathway is relevant not only to skeletal muscle (Figure S1K–
S1N), but not in liver, WAT, or brain. In these tissues, other
factors such as SIRT3 or SIRT6 may be responsible for regula-
tion of HIF-1a, or the metabolic status of the tissue at the time
of harvest may also be critical. Current dogma is that aging is
irreversible. Our data show that 1 week of treatment with a
compound that boosts NAD+ levels is sufficient to restore the
mitochondrial homeostasis and key biochemical markers of
muscle health in a 22-month-old mouse to levels similar to a
6-month-old mouse. Although further work is necessary, this
study suggests that increasing NAD+ levels and/or small
compounds that prevent HIF-1a stabilization or promote its
degradation might be an effective therapy for organismal decline
with age. In summary, these findings provide evidence for a
new pathway that controls carbon utilization and OXPHOS
independently of PGC-1a, a pathway that goes awry over time
but is readily reversible, with implications for treating aging and
age-related diseases.
EXPERIMENTAL PROCEDURES
Aging Cohorts, SIRT1-iKO, EglN1 KO, and SIRT1-Tg Mice and
NMNAT1 Electroporation
Wild-type C57BL/6J mice were from the National Institutes of Aging, NIH.
EglN1 KO, SIRT1-iKO, and SIRT1-Tg mice were described previously (Mina-
mishima et al., 2008; Price et al., 2012). For NMN experiments, mice were
given IP injections of 500 mg NMN/kg body weight per day or the equivalent
volume of PBS for 7 consecutive days at 6 PM and 8 AM on day 8 and were
sacrificed 4 hr after last injection. All animal care followed the guidelines and
was approved by Institutional Animal Care and Use Committees (IACUCs).
Adenovirus Generation and Mutagenesis
Adenoviruses were generated as described before (Rodgers et al., 2005) and
were used to infect cells for the time points described in the figures. HIF-1a andFigure 7. Increasing NAD+ Levels Rescues Age-Related Pseudohypox
(A) Immunoblot for HIF-1a and tubulin of 6- and 22-month-old AL and 22-month
(B) NAD+ levels in the same cohorts as in (A) (n = 5, *p < 0.05 versus 6-month-ol
(C) Expression of mitochondrially encoded genes of the same cohorts as in (A). Va
#p < 0.05 versus 22-month-old AL).
(D) Cytochrome c oxidase (COX) activity (n = 4, *p < 0.05 versus 6-month-old an
(E) NAD+ levels in 6- and 22-month-old mice treated with vehicle (PBS) or NMN (n
(F) Immunoblot for VHL, HIF-1a, and tubulin of same cohorts as in (E).
(G) Lactate levels of same cohorts as in (E) (n = 6, *p < 0.05 versus 6-month-old
(H) Expression of mitochondrially encoded genes of same cohorts as in (E). Values
#p < 0.05 versus 22-month-old PBS).
(I) ATP content of same cohorts as in (E) (n = 6, *p < 0.05 versus 6-month-old PB
(J) Expression of mitochondrially encoded genes in WT and EglN1 KO mice trea
(K) ATP content of same cohorts as in (J) (n = 5, *p < 0.05 versus WT PBS).
(L) Expression of mitochondrially encoded genes of WT and SIRT1 iKO mice trea
(M) Expression of mitochondrially encoded genes in primary myoblasts transduce
*p < 0.05 versus shNT vehicle).
(N) Nuclear-mitochondrial communication and its decline during aging. Nuclear
ensures the correct stoichiometry of OXPHOS subunits, but over time, a chron
encoded genes were ND1, Cytb, COX1, and ATP6.
Values are expressed as mean ± SEM. See also Figure S6.
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(Stratagene) according to the manufacturer’s instructions. Details about these
methodologies and the primers used for the mutagenesis can be found in the
Extended Experimental Procedures.
Generation of Primary Myoblasts, Rho0 Cells, Cell Culture
Treatments, Adenoviral Infections, and Gene Silencing
Primary myoblasts were isolated from PGC-1a/b KO, SIRT1 iKO, and PGC-1a
null mice as described before (Price et al., 2012). Rho0 cells were generated
by culturing the cells in media supplemented with 4 g/l glucose and 2 mM
pyruvate, 50 ng/ml ethidium bromide (Alfa aesar), and 100 mg/ml uridine
(Sigma-Aldrich) for 4 weeks to deplete mitochondrial DNA. Cells were treated
with the NMN (Sigma-Aldrich) and DMOG (Cayman) as described in the figure
legends, and details can be found in the Extended Experimental Procedures.
Gene silencing was achieved using pLKO.1 shRNAs for the genes of interest,
as described before (Gomes et al., 2012), andwas used after selectionwith eu-
karyotic marker of the vector. Details about these methodologies can also
been found in the Extended Experimental Procedures.
Mitochondrial Function
Cytochrome c oxidase and succinate dehydrogenase measurements were
determined pollarographically as described before (Gomes et al., 2012). Cyto-
chrome c oxidase was also measured spectrophotometrically using a
commercially available kit (Sigma-Aldrich) according to the manufacturer’s
instructions. ATP content was measured with a commercial kit (Roche)
according to the manufacturer’s instructions. Mitochondrial membrane poten-
tial and reactive oxygen species were measured by FACS as described (Bell
et al., 2011; Price et al., 2012). Electron microscopy was also determined as
described (Price et al., 2012). Details about these methodologies can be found
in the Extended Experimental Procedures.
Gene Expression and mtDNA Analysis
Total RNA and genomic DNA were isolated using a commercially available kit
(QIAGEN) according to the manufacturer’s instructions. cDNA was generated
using the iScript kit (BioRad). Gene expression and mtDNA were determined
by qPCR as described (Price et al., 2012). Details and primer sequences can
be found in the Extended Experimental Procedures.
Coimmunoprecipitation
Proteins from primary myoblasts were crosslinked using DSP (1 mM, Pierce),
after which the cells were lysed in a low-stringency IP buffer (0.05% NP-40,
50 mM NaCl, 0.5 mM EDTA, 50 mM Tris-HCl [pH 7.4]) supplemented with
protease inhibitor cocktail (Roche) and 25 U/ml endonuclease (Pierce). Endog-
enous HIF-1a protein was immunoprecipitated using anti-HIF-1a antibodyia and OXPHOS Dysfunction through a SIRT1-HIF-1a Pathway
-old CR mice.
d animals; #p < 0.05 versus 22-month-old AL).
lues normalized to 6-month-old mice (n = 5, *p < 0.05 versus 6-month-old mice;
imals; #p < 0.05 versus 22-month-old AL).
= 6, *p < 0.05 versus 6-month-old PBS; #p < 0.05 versus 22-month-old PBS).
PBS; #p < 0.05 versus 22-month-old PBS).
normalized to 6-month-old PBSmice (n = 6, *p < 0.05 versus 6-month-old PBS;
S; #p < 0.05 versus 22-month-old PBS).
ted with either vehicle (PBS) or NMN (n = 5, *p < 0.05 versus WT PBS).
ted with either vehicle (PBS) or NMN (n = 4, *p < 0.05 versus WT PBS).
d with NMNAT1 or nontargeting shRNA treated with either PBS or NMN (n = 4,
NAD+ levels regulate mitochondria via a PGC-1a-independent pathway that
ic pseudohypoxic response is activated, inhibiting OXPHOS. Mitochondrially
(Cayman) coated A/G magnetic beads (Pierce), and anti-IgG was used as
control. Imunoprecipitated proteins and input were run on SDS-PAGE and
were revealed with anti-HIF-1a (Cayman) and anti-c-Myc (Abcam) antibodies.
Details can be found in the Extended Experimental Procedures.
Chromatin Immunoprecipitation and Immunoblots
Chromatin immunoprecipitation was performed using a commercially avail-
able kit (Millipore) according to the manufacturer’s instructions and using
anti-HIF1a (Cayman), anti-c-Myc (Abcam), and anti-IgG as control. Immuno-
blots were performed as described (Price et al., 2012), and details can be
found in the Extended Experimental Procedures.
TFAM Promoter, VHL Promoter, HRE, and c-Myc Activity
TFAM promoter, VHL promoter, HRE, and c-Myc activity were determined
using a luciferase-based system. Luciferase activity was measured using the
Dual-Luciferase Reporter Assay System (Promega) with Renilla as the refer-
ence, and details about the constructs can be found in the Extended Experi-
mental Procedures.
NAD+ Measurement
NAD+ from skeletal muscle was quantified with a commercially available kit
(BioVision) according to the manufacturer’s instructions and as described
before (Gomes et al., 2012).
Statistical Analysis
Data were analyzed by a two-tailed Student’s t test. Statistical analysis was
performed using Excel software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and one table and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.11.037.
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